3D Global Biotech Inc. (TPEX:6808)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
61.10
-0.10 (-0.16%)
Apr 2, 2025, 1:40 PM CST
90.94%
Market Cap 4.76B
Revenue (ttm) 55.15M
Net Income (ttm) -29.41M
Shares Out 77.84M
EPS (ttm) -0.49
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 411,620
Average Volume 641,276
Open 61.20
Previous Close 61.20
Day's Range 60.40 - 61.70
52-Week Range 27.40 - 73.50
Beta 0.38
RSI 43.78
Earnings Date Mar 24, 2025

About 3D Global Biotech

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 33
Stock Exchange Taipei Exchange
Ticker Symbol 6808
Full Company Profile

Financial Performance

In 2023, 3D Global Biotech's revenue was 20.63 million, an increase of 51.24% compared to the previous year's 13.64 million. Losses were -57.95 million, -13.62% less than in 2022.

Financial Statements

News

There is no news available yet.